Steve Chen
Fondatore presso Alamar Biosciences, Inc. (California)
Profilo
Steve Chen is the founder of Advanced Cell Diagnostics, Inc. which was founded in 2006.
He held the title of Chief Operating Officer & Director.
Dr. Chen is also the founder of GenoSpectra, Inc., Alamar Biosciences, Inc. (California).
He previously worked as an Assistant Professor at the University of Maryland.
Dr. Chen earned a doctorate degree from the University of London.
Posizioni attive di Steve Chen
| Società | Posizione | Inizio |
|---|---|---|
Alamar Biosciences, Inc. (California)
 Alamar Biosciences, Inc. (California) BiotechnologyHealth Technology Alamar Biosciences, Inc. is an American California-based company founded by Yiyuan Yin, Yuling Luo, and Steve Chen. The company specializes in developing a next-generation proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies. Yuling Luo has been the CEO since incorporation. | Fondatore | - |
Precedenti posizioni note di Steve Chen
| Società | Posizione | Fine |
|---|---|---|
GenoSpectra, Inc.
 GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Fondatore | - |
| University of Maryland | Corporate Officer/Principal | - |
Advanced Cell Diagnostics, Inc.
 Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Fondatore | - |
Formazione di Steve Chen
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Advanced Cell Diagnostics, Inc.
Advanced Cell Diagnostics, Inc. BiotechnologyHealth Technology Advanced Cell Diagnostics, Inc. operates as a biotechnology company. It specializes in the emerging field of molecular pathology and developing cell- and tissue-based diagnostic tests for personalized medicine. The company was founded by Lou Yuling and Steve Chan in 2006 and is headquartered in Newark, CA. | Health Technology |
GenoSpectra, Inc.
GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Health Technology |
Alamar Biosciences, Inc. (California)
Alamar Biosciences, Inc. (California) BiotechnologyHealth Technology Alamar Biosciences, Inc. is an American California-based company founded by Yiyuan Yin, Yuling Luo, and Steve Chen. The company specializes in developing a next-generation proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies. Yuling Luo has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Steve Chen
